Growth factor isoform
AssigneeThe University of Bristol
InventorsDAVID BATES, STEVEN HARPER
Life of this patent
Estimating the term…
Abstract
An isolated VEGF polypeptide having anti-angiogenic activity, said polypeptide including the amino acid sequence of SEQ.ID NO.1, or variants thereof.
Claims31
An isolated VEGF polypeptide comprising an amino acid sequence at least 80% identical to the C-terminal 165 amino acid sequence from SEQ ID NO:17, wherein the polypeptide inhibits pro-angiogenic VEGF receptors activity.
2-5. (canceled)
7-8. (canceled)
An isolated nucleotide sequence comprising a nucleotide sequence that hybridises under stringent conditions to the nucleotide sequence of SEQ.ID.NO:2, or variants thereof.
11-18. (canceled)
(canceled)
(canceled)
26-32. (canceled)
(canceled)
40-41. (canceled)
(canceled)
47-59. (canceled)
An assay for the specific detection of VEGF165b in a sample comprising carrying out a polymerase chain reaction on at least a portion of the sample, using an annealing temperature of at least 59° C. and the following primer sequences:
- exon 4 (forward primer):
- GAGATGAGCTTCCTACAGCAC
- 9H (reverse primer):
- TTAAGCTTTCAGTCTTTCCTGGTGAGAGATCTGCA
- or variants thereof, wherein the variants retain the same annealing properties with respect to the VEG165 nucleotide sequence as the above primers.
61-62. (canceled)
Dependencies are inferred from the claim text.